The Global Nuclear Medicine market is forecast to grow at a CAGR of 9.1% during the forecasted period 2014-2020. The market growth is expected mainly due to the application of Nuclear Medicine in the treatment of diseases, with many players investing heavily in the research and development of new therapeutic agents. The report provides information on the current scenario, market segmentation on the basis of application and geography, and future forecasts on all prominent segments of the industry till 2020.
The segment-level analysis showed that Nuclear Medicine Diagnostics currently holds the biggest share of the total Nuclear Medicine market. However, the segment is expected to witness a slow growth in the future due to competition from conventional technologies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), high cost of Nuclear Medicine equipments and shortage of major diagnostic radiopharmaceuticals. Considering the growth rates, the therapeutics segment is expected to grow at a faster rate by 2020 with an increase in use of radiopharmaceuticals for targeted therapy.
The report also provides an insight into the market consolidation during 2014 & 2015. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities in the Global Nuclear medicine market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving Nuclear Medicine market.
- Advanced Accelerator Applications
- Cardinal Health Inc.
- GE Healthcare
- Lantheus Medical Imaging
- Nordion Inc.
1. Analyst View
2. Research Methodology
3. Drivers and Challenges
4. Industry Overview
5. Recent Trends and Developments
6. Competitive Landscape
For more information visit http://www.researchandmarkets.com/research/b59kwz/global_nuclear